drugset / Trial / NCT01376063

Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects

NCT01376063

Phase 1 Completed 20 enrolled Kyntra Bio
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The primary purpose of this study is to assess the effect of multiple doses of FG-4592 on the plasma pharmacokinetic of rosiglitazone in healthy adult subjects.

Timeline

Start
2010-03
Primary completion
2010-05
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule
Subject Roxadustat Small molecule

Indications

No indication recorded.